VEGFA and neoplasm: Furthermore, the lack of any evident combinatorial effects between bevacizumab and PLX4720 on tumor vessels, and on the amount of murine VEGF detected in the xenografts (not shown), suggests that the enhanced antitumor activity observed with COMBO is likely independent of angiogenesis.